Union Bankshares Has Boosted Apple (AAPL) Stake; Tesaro (TSRO) Sentiment Is 1.01

Apple Inc. (NASDAQ:AAPL) Logo

Tesaro Inc (TSRO) investors sentiment decreased to 1.01 in Q4 2017. It’s down -0.20, from 1.21 in 2017Q3. The ratio has worsened, as 111 investment managers opened new or increased stock positions, while 110 reduced and sold their positions in Tesaro Inc. The investment managers in our database now possess: 57.95 million shares, down from 58.28 million shares in 2017Q3. Also, the number of investment managers holding Tesaro Inc in top ten stock positions was flat from 4 to 4 for the same number . Sold All: 46 Reduced: 64 Increased: 72 New Position: 39.

Union Bankshares Corp increased Apple Inc (AAPL) stake by 8.47% reported in 2017Q4 SEC filing. Union Bankshares Corp acquired 4,201 shares as Apple Inc (AAPL)’s stock declined 3.81%. The Union Bankshares Corp holds 53,784 shares with $9.10 million value, up from 49,583 last quarter. Apple Inc now has $932.76 billion valuation. The stock increased 3.92% or $6.94 during the last trading session, reaching $183.83. About 53.48M shares traded or 41.31% up from the average. Apple Inc. (NASDAQ:AAPL) has risen 19.49% since May 5, 2017 and is uptrending. It has outperformed by 7.94% the S&P500.

Nea Management Company Llc holds 35.27% of its portfolio in Tesaro, Inc. for 10.28 million shares. Oracle Investment Management Inc owns 891,242 shares or 14.64% of their US portfolio. Moreover, Camber Capital Management Llc has 3.45% invested in the company for 850,000 shares. The Switzerland-based Bb Biotech Ag has invested 2.44% in the stock. Rock Springs Capital Management Lp, a Maryland-based fund reported 548,500 shares.

Since January 1, 0001, it had 9 buys, and 7 insider sales for $61.19 million activity.

Ratings analysis reveals 55% of Tesaro’s analysts are positive. Out of 11 Wall Street analysts rating Tesaro, 6 give it “Buy”, 0 “Sell” rating, while 5 recommend “Hold”. The lowest target is $97.0 while the high is $182.0. The stock’s average target of $141.50 is 183.23% above today’s ($49.96) share price. TSRO was included in 11 notes of analysts from August 30, 2016. On Monday, October 10 the stock rating was maintained by Wedbush with “Outperform”. Lake Street maintained the stock with “Buy” rating in Monday, November 7 report. The firm has “Overweight” rating by Piper Jaffray given on Wednesday, April 12. Bank of America initiated it with “Neutral” rating and $97.0 target in Tuesday, August 30 report. The stock of Tesaro, Inc. (NASDAQ:TSRO) has “Neutral” rating given on Monday, February 27 by Robert W. Baird. The firm has “Overweight” rating given on Friday, January 13 by Morgan Stanley. The rating was maintained by FBR Capital on Monday, October 10 with “Outperform”. The stock of Tesaro, Inc. (NASDAQ:TSRO) has “Outperform” rating given on Monday, October 10 by RBC Capital Markets. The stock has “Mkt Perform” rating by Raymond James on Friday, November 4. The firm has “Neutral” rating given on Monday, April 10 by Janney Capital.

Tesaro, Inc., an oncology-focused biopharmaceutical company, identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States. The company has market cap of $2.74 billion. It markets Rolapitant, a neurokinin-1, or NK-1, receptor antagonist for the prevention of chemotherapy induced nausea and vomiting under the VARUBI brand name. It currently has negative earnings. The firm is also developing Niraparib, an orally active and potent poly polymerase inhibitor, which is in various clinical trials to treat ovarian or breast cancers.

Analysts await Tesaro, Inc. (NASDAQ:TSRO) to report earnings on May, 8. They expect $-2.77 EPS, down 8.63% or $0.22 from last year’s $-2.55 per share. After $-3.35 actual EPS reported by Tesaro, Inc. for the previous quarter, Wall Street now forecasts -17.31% EPS growth.

More notable recent Tesaro, Inc. (NASDAQ:TSRO) news were published by: Seekingalpha.com which released: “TESARO’s (TSRO) CEO Lonnie Moulder on Q1 2018 Results – Earnings Call Transcript” on May 04, 2018, also Globenewswire.com with their article: “TESARO Announces Participation in Two Investor Conferences” published on May 01, 2018, Seekingalpha.com published: “Tesaro: Time To Buy” on April 13, 2018. More interesting news about Tesaro, Inc. (NASDAQ:TSRO) were released by: Streetinsider.com and their article: “After-Hours Stock Movers 05/03: (CVGI) (VIAV) (SHAK) Higher; (FLR) (ANET) (TSRO) Lower (more…)” published on May 03, 2018 as well as Seekingalpha.com‘s news article titled: “TESARO’s niraparib shows treatment effect in late-line ovarian cancer” with publication date: April 24, 2018.

The stock increased 3.31% or $1.6 during the last trading session, reaching $49.96. About 1.79 million shares traded or 74.19% up from the average. Tesaro, Inc. (TSRO) has declined 63.82% since May 5, 2017 and is downtrending. It has underperformed by 75.37% the S&P500.

Among 56 analysts covering Apple Inc. (NASDAQ:AAPL), 37 have Buy rating, 1 Sell and 18 Hold. Therefore 66% are positive. Apple Inc. has $235 highest and $11 lowest target. $175.39’s average target is -4.59% below currents $183.83 stock price. Apple Inc. had 413 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Brean Capital on Wednesday, April 27 with “Buy”. The rating was maintained by Credit Suisse on Monday, April 4 with “Outperform”. UBS maintained the shares of AAPL in report on Friday, January 5 with “Buy” rating. The firm has “Buy” rating by UBS given on Wednesday, May 2. The company was maintained on Friday, June 9 by Drexel Hamilton. The firm has “Neutral” rating given on Wednesday, January 6 by Rosenblatt. The stock has “Buy” rating by Wells Fargo on Friday, September 4. The firm earned “Buy” rating on Tuesday, June 13 by Morgan Stanley. UBS maintained Apple Inc. (NASDAQ:AAPL) rating on Tuesday, March 27. UBS has “Buy” rating and $19000 target. On Friday, February 2 the stock rating was downgraded by Bernstein to “Hold”.

Since December 7, 2017, it had 0 insider purchases, and 5 sales for $26.72 million activity. Maestri Luca sold $6.83 million worth of stock. SCHILLER PHILIP W sold $11.56M worth of stock or 69,491 shares. Riccio Daniel J. sold $2.73M worth of stock.

Tesaro, Inc. (NASDAQ:TSRO) Institutional Positions Chart